Category Archives: FDA

Exclusive: White House Task Force Echoes Pharma Proposals

Posted on June 20, 2017 by bcolbath42

KAISER HEALTH FOUNDATION By Emily Kopp June 16, 2017 President Donald Trump speaks during an event in the Roosevelt Room of the White House. (Jabin Botsford/The Washington Post via Getty Images) President Donald Trump repeatedly talks tough about reining in the pharmaceutical … Continue reading →

Posted in AHCA, FDA, Health Care, Trump | Tagged , , | Leave a comment

Descent Into Secrecy: Senate Health Talks Speak To Steady Retreat From Transparency

Posted on June 19, 2017 by bcolbath42

Kaiser Health News REPEAL & REPLACE WATCH By Julie RovnerJune 14, 2017 (Photo courtesy of the Office of the Architect of the Capitol) Congress struggling to finish a huge budget reconciliation bill. A GOP president pushing a major overhaul of … Continue reading →

Posted in American Health Care Act, Congress, Environment, FDA, GOP, Medicaid, Politics, Trump | Leave a comment

Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia.

Posted on June 1, 2017 by bcolbath42

Before he was named Trump’s health secretary, Price took a congressional trip to Australia and pressed officials to extend protections for drug companies in an international trade agreement. by Robert Faturechi ProPublica, June 1, 2017, 8 a.m. Then-Rep. Tom Price, … Continue reading →

Posted in FDA, Trump, USDA | Tagged , , , | Leave a comment